Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Jonathan J. Dutton, MD, PhD, FACS
Ophthalmic Plastic and Reconstructive Surgery
Department of Ophthalmology
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Jonathan Dutton is a Professor Emeritus of Ophthalmic Plastic and Reconstrucitve Surgery and Ophthalmic Oncology at the University of North Carolina at Chapel Hill, North Carolina, United States. He formerly specialized in orbital diseases, intraocular oncology, and reconstructive eyelid and lacrimal surgery.
He has pioneered research in orbital reconstruction and treatment of spastic eyelid disease. His practice covers the full scope of problems related to the eyelids and orbits, including blepharospasm, eyelid malpositions, tearing disorders, thyroid eye disease, eyelid and orbital trauma, and periocular malignancies. He has a particular interest in intraocular malignancies, with internationally recognized expertise in treatment of choroidal malignant melanoma. He served as a principle investigator for the national collaborative melanoma treatment trial and perform episcleral radioactive plaque therapy for treatment of intraocular melanoma.
Anatomic Considerations in Thyroid Eye Disease
Effect of Radiation Therapy on Intraocular Pressure in Patients With Graves’ Orbitopathy
Thyroid Eye Disease: Therapy in the Active Phase
Massachusetts Eye and Ear – Center for Thyroid Eye Disease and Orbital SurgeryThe multidisciplinary Center for Thyroid...
University of Minnesota – Center for Thyroid Eye DiseaseIf you experience dry or watery eyes, re...
Efficacy of Orbital Radiotherapy in Moderate-to-Severe Active Graves’ Orbitopathy Including Long-Lasting Disease: ...Background: We aimed to explore the eff...
Efficacy and Safety of Mycophenolate Mofetil in Patients With Active Moderate-to-Severe Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
Linda R. Dagi, MDDr. Linda Dagi is the Director of Adult ...
Predictive Score for the Development or Progression of Graves’ Orbitopathy in Patients With Newly Diagnosed Gr...Objective: To construct a predictive sc...
Teprotumumab for Treatment of Thyroid Eye Disease Meets Endpoints in Phase 3 StudyResults from the phase 3 OPTIC study sho...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.